Kogenix Therapeutics Inc., of Boston, said in a paper published in Nature's Molecular Psychiatry from Universitat Autonoma de Barcelona and the Vall d'Hebron Research Institute, it showed for the first time cognitive improvements in old animals that were treated at younger age with secreted alpha Klotho gene therapy.